Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Cyclophosphamide is effective in stabilizing rapidly deteriorating secondary progressive multiple sclerosis.
JCV GCN in a natalizumab-treated MS patient is associated with mutations of the VP1 capsid gene.
Cognitive impairment as unusual first manifestation in late-onset relapsing-remitting multiple sclerosis.
[The comparative study of efficacy and tolerability of intramuscular introduction of beta-interferon-1a in adults and adolescents with remitting multiple sclerosis.]
The biological significance of brain barrier mechanisms: help or hindrance in drug delivery to the central nervous system?
Development of a Computer-aided Diagnostic System for Detecting Multiple Sclerosis Using Magnetic Resonance Images.
[Multiple sclerosis: new approaches to comprehensive treatment and rehabilitation using the method of reflexology].
Immune reconstitution inflammatory syndrome in a patient treated with natalizumab presenting progressive multifocal leukoencephalopathy.
MYRAC Rx
Ximino
Mu opioid receptor activation modulates Toll like receptor 4 in murine macrophages.
Effects of Dalfampridine Extended-Release Tablets on 6-Minute Walk Distance in Patients With Multiple Sclerosis: A Post Hoc Analysis of a Double-Blind, Placebo-Controlled Trial.
Multiple Sclerosis: Validation of MR Imaging for Quantification and Detection of Iron.
No Regional Gray Matter Atrophy Differences between Pediatric- and Adult-Onset Relapsing-Remitting Multiple Sclerosis.
Eosinophilic Fasciitis Occurring under Treatment with Natalizumab for Multiple Sclerosis.
Behçet's Disease Presenting with Acute Transverse Myelitis: MRI Findings and Review of the Nosology. A Case Report.
Physiotherapy as an immunoactive therapy? A pilot study.
Revisiting The Multiple Sclerosis Functional Composite: proceedings from the National Multiple Sclerosis Society (NMSS) Task Force on Clinical Disability Measures.
Association between multiple sclerosis and chronic periodontitis: a population-based pilot study.
Vitamin D, HLA-DRB1 and Epstein-Barr virus antibody levels in a prospective cohort of multiple sclerosis patients.
Daphnetin Alleviates Experimental Autoimmune Encephalomyelitis via Regulating Dendritic Cell Activity.
Spatiotemporal distribution of white matter lesions in relapsing-remitting and secondary progressive multiple sclerosis.
Inflammatory Response and Chemokine Expression in the White Matter Corpus Callosum and Gray Matter Cortex Region During Cuprizone-Induced Demyelination.
Patient perceptions of multiple sclerosis and its treatment.
Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo.

Pages